Paris, September 18th, 2023 – Essling Capital announces the closing of its first global thematic co-investment fund, Essling Co-Invest Healthcare (ECI HC), dedicated to the healthcare sector, at nearly €100 million. In parallel, Essling Capital continues with its global generalist co-investment fund series with the launch of the fourth vintage, Essling Co-Invest 4 (ECI 4). Its first closing will take place before the end of September.

First thematic fund launched in 2022 and largely deployed
Essling Co-Invest Healthcare has already completed 10 investments, including 4 in North America, 3 in the UK and 3 in Europe (France, Germany and Italy). An 11th and final investment has yet to be finalised. In addition to geographical diversification, these investments cover a wide range of deal sizes (from €50 million to €7 billion) and cover different segments of the healthcare sector (HealthTech, MedTech, Pharmaceuticals and Services).

The fourth vintage of the global co-investment program already in high demand
ECI 4 offers the same strategy as the last three vintages: investing as a minority shareholder alongside funds specialised in small, mid or large cap LBOs, with broad geographical and sector diversification. ECI 4 will replicate the characteristics of previous vintages of ECI funds: a targeted investment period of 12 to 18 months and pricing based on the capital invested, during the investment period.

Overall, the Essling Co-Investment program has raised over €500 million since its launch in 2016 and has completed 36 deals alongside first tier partners in both Europe and the US. The team screens over 250 co-investment deals every year. It adopts an opportunistic approach, with no sector or deal size constraints.

“With this new vintage, we are confident in our ability to meet the expectations of our investors and partners, who are convinced by our innovative approach to co-investment,” says Domnin de Kerdaniel, CEO of Essling Capital.”

“In the current period of market dislocation, our deal flow is substantial and of good quality, generated alongside highly experienced managers looking for professional partners with strong execution capabilities. We have already identified a number of investment opportunities for this new fund, which are currently being analysed and should materialise in the coming weeks,” adds Arnaud Lipkowicz, Partner and Head of Co-Investment.”

About Essling Capital
Essling Capital is an independent asset management company specialising in private assets. Essling Capital manages and advises c. €600 million in France and internationally. Essling Capital is regulated by the AMF (Autorité des Marchés Financiers), authorisation no. GP – 17000016.
To better respond to the changing market for private assets, Essling Capital offers its investors innovative investment solutions based on two strategies:

  • Co-investment (“Essling Co-Invest”), with generalist or thematic global co-investment funds (including one fund 100% dedicated to healthcare) and single-asset funds;
  • Lead investment, with Essling Expansion, a Growth Small Cap fund targeting high-growth companies headquartered in France in the tech/digital, software, healthcare and B2B services sectors.

• • •

Medias Relations – Essency Communications

Armelle de Selancy
+33 6 72 59 62 90 –

Marie-Claire Martin
+33 6 66 58 84 28 –